• J&J Drugs to Create Next Wave of Growth, Duato Says
  • J&J Sees 10 Products Submitted for Approval by 2017
  • Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
  • Hedge Funds Trail S&P 500 by 10 Percentage Points, Goldman Says
  • Swiss Billionaires Buy Merck Geneva Building for Biotech Campus
  • Harvard’s Largest Gift Doubles With Second Wyss Donation
  • Medtronic’s Heart Rhythm Devices Show Signs of Growth
  • Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’
  • J&J Will Stop Sales of Metal-on-Metal Hip Replacements
  • Final Soccer World Cup Sponsor to Spend $50 Million in 15 Months
  • J&J Wins Expanded Approval of Simponi for Bowel Disease
  • Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
  • Primecap Rides Health to Top Growth Fund: Riskless Return
  • Bonanza Creek’s 19% Surge Canceled as Other Swings Stands
  • Vaginal Bulge Surgery Fails in One in Four Women in Study
« Previous 1 2 Next »